GlassScriptPhysician profile
Adam Hintz
NPI 1427444884
$2,228.73
in general payments reported to CMS, 2019-2025
8 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $295 · 2021: $53.02 · 2022: $343 · 2023: $425 · 2024: $123 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,158.37 | 2019-2025 | Intracept Rf Probe |
| Averitas Pharma INC. | $243.19 | 2023-2024 | Qutenza |
| Abbott Laboratories | $235.22 | 2019-2020 | |
| Stratus Medical, LLC | $185.56 | 2023 | Nimbus |
| Curonix LLC | $151.93 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $124.99 | 2022 | |
| Stimwave Technologies Incorporated | $111.41 | 2022 | |
| Avanos Medical | $18.06 | 2025 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Hintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.